Hormone therapy improves life expectancy
Patients with metastatic breast cancer have a better life expectancy if they are treated with hormone therapy (MUMC+ news).
News
462 results
-
-
Improved survival after kidney transplantation: revolutionary assay developed by VitaK
VitaK Innovation develops new medical diagnostics device TransCare (Brightlands news).
-
'Good cholesterol' also has negative effects
Study published in Cell Metabolism by University Maastricht/Maastricht UMC+ reveals increase in inflammatory response of immune cells due to HDL.
-
World travellers often import multidrug-resistant intestinal bacteria
People who travel to distant destinations often import multidrug-resistant intestinal bacteria known as ESBL-producing bacteria, which are resistant to common antibiotics.
-
Will our future decisions be based on big data?
Data science is playing an increasingly important role in research, education, business, society and medicine (appointment André Dekker).
-
COACH approach works
Long-term improvement for the majority of participating children with overweight or obesity (MUMC+ News).
-
Maastricht University develops innovative learning environment on Brightlands campus
UM is developing an innovative learning environment in the field of biobased materials on the Brightlands Chemelot Campus in Sittard-Geleen.
-
Monitoring Bacteria in Crohn’s Disease
Possible alternative for endoscopy to control Crohn's disease (MUMC+ news)
-
Effective muscle building by administering protein during sleep
The administration of proteins during sleep is an effective way to promote muscle building (PhD conferral Bart de Groen).
-
Six million euro grant for cancer therapy research
Researchers at MAASTRO CLINIC and Maastricht UMC+/Maastricht University receive a six million euro grant from the European Commission to investigate treatment of metastatic lung tumours with a combination of radio therapy and immunotherapy in clinical practice
